A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-04-01
- Last Posted Date
- 2019-08-20
- Lead Sponsor
- Xencor, Inc.
- Target Recruit Count
- 105
- Registration Number
- NCT02725515
- Locations
- 🇺🇸
Emory University School of Medicine, Atlanta, Georgia, United States
🇺🇸UC San Diego, La Jolla, California, United States
🇺🇸Loma Linda University, Loma Linda, California, United States
Study to Evaluate the Effect of XmAb®5871 on Disease Activity in Patients With IgG4-Related Disease (RD)
- First Posted Date
- 2016-04-01
- Last Posted Date
- 2018-12-07
- Lead Sponsor
- Xencor, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT02725476
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic Dermatitis
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-05-28
- Last Posted Date
- 2017-01-24
- Lead Sponsor
- Xencor, Inc.
- Target Recruit Count
- 72
- Registration Number
- NCT02148744
- Locations
- 🇺🇸
Parexel Baltimore Early Phase Clinical Unit, Baltimore, Maryland, United States
Safety and Tolerability of XmAb®5574 in Chronic Lymphocytic Leukemia
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-07-13
- Last Posted Date
- 2014-04-21
- Lead Sponsor
- Xencor, Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT01161511
- Locations
- 🇺🇸
Sarah Cannon Research Institute, Nashville, Tennessee, United States
🇺🇸Medical College of Georgia, Augusta, Georgia, United States
🇺🇸The Ohio State University, Columbus, Ohio, United States
Safety Study of XmAb®2513 to Treat Hodgkin Lymphoma or Anaplastic Large Cell Lymphoma
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-02-04
- Last Posted Date
- 2014-04-21
- Lead Sponsor
- Xencor, Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT00606645
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
🇺🇸Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
© Copyright 2024. All Rights Reserved by MedPath